Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balazy, M.
Right arrow Articles by Wolin, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balazy, M.
Right arrow Articles by Wolin, M. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 48, 32009-32015, November 27, 1998


S-Nitroglutathione, a Product of the Reaction between Peroxynitrite and Glutathione That Generates Nitric Oxide*

Michael BalazyDagger , Pawel M. Kaminski, Kaiyun Mao, Jianzhen Tan, and Michael S. Wolin

From the Departments of Pharmacology and Physiology, New York Medical College, Valhalla, New York 10595

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Peroxynitrite (ONOO-) has been shown in studies on vascular relaxation and guanylate cyclase activation to react with glutathione (GSH), generating an intermediate product that promotes a time-dependent production of nitric oxide (NO). In this study, reactions of ONOO- with GSH produced a new substance, which was characterized by liquid chromatography, ultraviolet spectroscopy, and electrospray tandem mass spectrometry. The mass spectrometric data provided evidence that the product of this reaction was S-nitroglutathione (GSNO2) and that S-nitrosoglutathione (GSNO) was not a detectable product of this reaction. Further evidence was obtained by comparison of the spectral and chromatographic properties with synthetic standards prepared by reaction of GSH with nitrosonium or nitronium borofluorates. Both the synthetic and ONOO-/GSH-derived GSNO2 generated a protonated ion, GSNO2H+, at m/z 353, which was unusually resistant to decomposition under collision activation, and no fragmentation was observed at collision energy of 25 eV. In contrast, an ion at m/z 337 (GSNOH+), generated from the synthetic GSNO, readily fragmented with the abundant loss of NO at 9 eV. Reactions of ONOO- with GSH resulted in the generation of NO, which was detected by the head space/NO-chemiluminescence analyzer method. The generation of NO was inhibited by the presence of glucose and/or CO2 in the buffers employed. Synthetic GSNO2 spontaneously generated NO in a manner that was not significantly altered by glucose or CO2. Thus, ONOO- reacts with GSH to form GSNO2, and GSNO2 decomposes in a manner that generates NO.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Exposure of vascular tissue to peroxynitrite (ONOO-)1 results in a prolonged relaxation (1) that appears to be mediated through a glutathione (GSH)-dependent regeneration of NO (2). Peroxynitrite has also been observed to stimulate guanylate cyclase activity in a thiol-dependent manner in vascular endothelial and smooth muscle preparations (3, 4). Whereas the reaction of ONOO- with GSH has been reported to form small amounts of S-nitroso-GSH (GSNO) (3, 5), our previous studies detected a different product of this reaction, which was isolated and demonstrated to possess potent vascular relaxant activity (2). Examination of the reaction of nitrogen dioxide (NO2) with GSH detected the formation of what appears to be the same product as that observed in the reaction with ONOO- (6). Because the biologically active metabolite of these reactions co-migrated on HPLC with a the product of a reaction between nitrosonium borofluorate (NO2BF4) and GSH, the vascular relaxant detected was suggested to be a nitrated product of GSH (GSNO2) (6). Thus, additional studies are needed to identify the biologically active substances derived from the reaction of GSH with ONOO-.

Peroxynitrite is also known to undergo additional reactions in the presence of physiological buffered systems and GSH. One of the first observed actions of ONOO- on thiols was that it caused oxidation reactions, and an analysis of products of these reactions resulted in a hypothesis that nitrated thiols were a key unstable intermediate formed during these reactions (7, 8). Recent studies have also provided evidence that thiol radicals seem to be one of the major initial products of the reaction of ONOO- with thiols (9, 10). Peroxynitrite appears to react with glucose and other hydroxylated compounds to produce relatively stable products that cause tissue- or thiol-dependent generation of NO and a prolonged relaxation of vascular tissue (11, 12). However, the vasoactive products formed from reactions with glucose seem to be significant only at very elevated levels of ONOO- (13). Peroxynitrite also reacts with CO2/bicarbonate to generate an intermediate that is a potent nitrating agent (14-17). Thus, ONOO- may interact with additional components of tissues and buffers to form biologically active metabolites. The purpose of this study was to determine whether the reaction of ONOO- with GSH generates GSNO2 and to examine aspects of how the formation GSNO2 potentially participates in the generation of NO from ONOO-.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Nitric Oxide Measurements-- Head space NO measurements were determined employing a NO chemiluminescence analyzer (model 20B, Sievers Instruments, Boulder, CO), using a slightly modified version of the method of Brien et al. (18) that was adapted for our previous studies on ONOO- and NO2 (2, 6). To quantify the amount of NO produced in the head space gas derived from 0.4 mM ONOO- or 0.1 mM GSNO2, the following protocols were applied: Fernbach flasks (6 ml) containing a 2-ml final volume of 25 mM potassium phosphate or 25 mM bicarbonate buffer (pH 7.4) in the presence or absence of combinations of 1 mM GSH and 5.6 mM glucose were incubated at 37 °C equilibrated under an atmosphere of argon or 95% N2-5% CO2, respectively. To the sealed Fernbach flasks, aliquots of deoxygenated ONOO- or GSNO2 were injected, and the flasks containing the various experimental conditions were allowed to accumulate NO in the head space for 30 min. After 30 min, a single 0.5-ml aliquot was taken of the head space gas from each sealed Fernbach flask to quantitate the amount of NO produced from each experimental condition employing the Sievers NO analyzer. Under these severely hypoxic conditions, NO is stable over the 30-min accumulation period. The amount of NO formed was quantified, after subtraction of an injection artifact blank, based on NO standards and recovery of authentic NO from the Fernbach flask containing 2 ml of buffer.

Chemistry-- Peroxynitrite was prepared from sodium nitrite and H2O2 in a quenched-flow reactor with minor modifications (19). H2O2 and oxygen were removed from the peroxynitrite solution by adding catalytic amounts of MnO2 followed by bubbling with a gentle stream of dry nitrogen for 1 h. ONOO- was concentrated by freezing the ONOO- solution for overnight at -20 °C, and the concentrated top yellow layer was carefully thawed and transferred to a clean glass tube. The concentration of peroxynitrite was determined spectrophotometrically by measurement of absorbance at 302 nm in 0.1 N NaOH (A302 = 1670 M-1·cm-1). The stock solution contained 170-190 mM ONOO-, and dillutions were made in 0.1 N NaOH. The reaction of GSH (1 mM) with ONOO- (1 mM) was carried in 0.5 ml of phosphate buffer (pH 7.4) in a stopper-capped glass tube with constant stirring at room temperature. The aliquots (20 µl) of the reaction mixture were taken at various time points and analyzed by injection into a reverse-phase HPLC column (RP-HPLC). In control experiments, the GSH was reacted with decomposed ONOO- (30 min at 37 °C). The products of the reaction were analyzed by RP-HPLC and electrospray ionization tandem mass spectrometry (ESI/MS/MS).

Preparation of Standards-- GSNO and GSNO2 were prepared as described previously (6). Briefly, GSNO2 was prepared by addition of thiol nitrating reagent, nitronium tetrafluoroborate (NO2BF4, 0.1 M) to 25 mM GSH dissolved in 0.5 M phosphate-buffered saline (pH 7.4), and the mixture was the subjected to purification by HPLC. The NO2BF4 was prepared immediately before use as a 1 M solution in 0.1 N HCl. GSNO was obtained via analogous reaction with nitrosonium tetrafluoroborate (NOBF4). Overnight storage of GSNO and GSNO2 at -20 °C allowed us to obtain enriched preparations of these compounds as concentrated upper pink-colored layers, which were collected, purified by RP-HPLC, and analyzed by ESI/MS/MS.

ESI/MS/MS-- Mass spectrometry was performed on a triple quadrupole tandem mass spectrometer (TSQ 700, Finnigan-MAT, San Jose, CA) equipped with an ESI interface. Both the electrospray needle and the skimmer were operated at ground potential, whereas the electrospray chamber and metalized entrance of the glass capillary were operated at -3.5 kV in the positive ion mode. The mass spectrometer was operated at unit resolution across its entire mass range. Nitrogen was used for all inlet gases other than the collision gas, which was argon. The collision gas thickness for tandem mass spectrometry experiments was 250-300 ×1012 molecules/cm2. All samples (0.5-1 pmol/µl) were dissolved in deionized water containing 5% acetonitrile and 0.01% acetic acid and infused into the electrospray ion source by using a syringe pump (model 22, Harvard Apparatus, South Natick, MA) at a flow of 1 µl/min for 5 min through a 100 µm-inner diameter fused silica capillary. The capillary transfer tube temperature was kept at 150 °C. The curtain gas flow was 1.2 liters/min, and the nebulizer gas flow was held at 0.9 liter/min. Collision-induced dissociations were induced with 1.4 torr, resulting in 50-60% decrease in ion transmission. Collision energy ranged from 8 to 25 eV.

HPLC Analyses-- Samples were injected into a 1050 HPLC system (Hewlett-Packard, Palo Alto CA) equipped with a quaternary pump and a variable wavelength UV detector and operated by a ChemStation data system. The compounds were analyzed on a C18 Hypersil column (250 × 4.6 mm, Beckman Instruments) that was eluted isocratically with acetonitrile (5%, v/v) in water (containing acetic acid, 0.01% v/v, pH 4) at a flow of 1 ml/min. The effluent from the column was collected in 1-ml fractions using a Gilson FC203B fraction collector. The chromatograms were obtained by monitoring UV absorbance at 215 and 344 nm. Fractions containing UV light-absorbing substances were subjected to further analyses.

UV Spectroscopy-- Samples (1 ml) containing either GSNO2 or GSNO, freshly purified by HPLC, were placed in a semimicro-UV 1-ml quartz cuvette (QS 1.000, Fisher Scientific), and the spectra were recorded using a diode array spectrophotometer (Hewlett-Packard HP 8452A). The spectra were taken from 200 to 450 nm at a scan rate of 250 nm/s. Specific absorbance at 334 nm was 980 M-1·cm-1 for GSNO2 and 800 M-1·cm-1 for GSNO.

Statistical Analysis-- The data were analyzed by one- and two-way analysis of variance for multiple comparisons employing a Bonferroni's modified t test to determine statistical significance for all studies. Results are reported as means ± S.E., with n equal to the number of separate determinations in chemical reactions. p < 0.05 was used to determine statistical significance.

Materials-- Reduced glutathione was from Calbiochem. NO2BF4 and NOBF4 were purchased from Aldrich. All solvents were of highest chromatographic grade.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Properties of NO Generation from Reactions of ONOO- with GSH and from GSNO2-- Our previous work demonstrated that the release of NO from the reaction of ONOO- with GSH was approximately linear for the first 30 min, and it decreased substantially after this time point (2). This observation was used to design the experiments shown in Figs. 1 and 2. The data in Fig. 1 show that GSH stimulates the release of NO from ONOO- as previously reported (2). Generation of NO was significantly lower in CO2/bicarbonate buffer than in phosphate buffer. This is consistent with a recent observation that CO2 catalyzes ONOO- decomposition via formation of an unstable intermediate nitrosoperoxycarbonate (ONOOCO2-), thereby accelerating formation of nitrate (14). Addition of glucose alone had no effect on NO release from ONOO-. However, as compared with the reaction with GSH alone (in phosphate buffer), about 50% less NO was detected when ONOO- was reacted with GSH in the presence of glucose.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of absence and presence of combinations of glutathione (1 mM) and glucose (5.6 mM) on the release of NO from 0.4 mM ONOO- dissolved in CO2/bicarbonate- or phosphate-containing buffers (pH 7.4). Experiments were conducted as described under "Experimental Procedures" (n = 11-12). Note that bicarbonate buffer significantly (p < 0.05) decreased the detection of NO as compared with phosphate buffer under all conditions, glutathione significantly (p < 0.05) increased NO release under all conditions except in glucose-free bicarbonate-containing solution, and glucose decreased (p < 0.05) the formation of NO from peroxynitrite + glutathione in phosphate buffer.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of absence and presence of combinations of glutathione (1 mM) and glucose (5.6 mM) on the release of NO from 0.1 mM GSNO2 dissolved in CO2/bicarbonate- or phosphate-containing buffers (pH 7.4). Experiments were conducted as described under "Experimental Procedures" (n = 11-12). Note the depression (p < 0.05) of NO release by glutathione and that bicarbonate buffer significantly lowered (*, p < 0.05) NO formation from GSNO2 + GSH in the absence of glucose.

The observation of a prolonged release of NO from the interaction of ONOO- with GSH suggests that ONOO- reacted with GSH producing an intermediate compound, possibly GSNO2 (2), which released NO. This hypothesis is supported by experiments shown in Fig. 2, which demonstrate that synthetic GSNO2 spontaneously releases NO in the buffer systems employed. In preliminary experiments, it was confirmed that the amount of NO formed from GSNO2 at 15 min was approximately half that detected at 30 min. Data in Fig. 2 indicate that the presence of glucose and CO2/bicarbonate had minimal inhibitory effects of NO release from GSNO2, whereas the data in Fig. 1 demonstrate that the presence of glucose or CO2/bicarbonate suppresses the generation of NO from ONOO-. Thus, the actions of glucose and CO2/bicarbonate on NO release seem to originate primarily from an action of these buffers on the ONOO- and not on the stability of GSNO2.

The maximal yield of NO from GSNO2 in the absence of added GSH at the 30 min time point was approximately 30-40%, and this was observed to decrease on addition of increasing concentrations of GSH. In separate experiments, which determined the amount of NO released from GSNO2 in the absence and presence of 1 mM GSH, it was confirmed that NO generation at 30 min was reduced by 43% in the presence of GSH relative to the control. A reaction of GSH with GSNO2 resulted most likely in the formation of nitrite and disulfide (GSSG). This explanation is based on a previous observation that was suggested as an explanation for the observed decreased formation of NO from tert-butyl thionitrate via a competitive reaction with cysteine (20). Whereas CO2/bicarbonate buffer did not affect the production of NO from GSNO2 in the presence of GSH and glucose, NO formation in the absence of glucose was further decreased by an additional 46% in CO2/bicarbonate buffer (Fig. 2). A strong additional inhibitory effect of GSH on NO release from GSNO2 in the presence of CO2/bicarbonate and in the absence of glucose (Fig. 2, p < 0.05) may explain the minimal release of NO from ONOO- under the same conditions (Fig. 1).

Characterization of GSNO2-- Treatment of GSH with peroxynitrite at pH 7.4 followed by RP-HPLC analysis using a mobile phase containing water and 0.1% acetonitrile revealed the presence of several substances (Fig. 3). Compound a was confirmed to be unreacted glutathione because it coeluted with GSH, and its ESI/mass spectrum (Fig. 4) was identical with that of intact GSH. A novel compound b, eluting at 7.1 min., was detected as a product of ONOO- reaction with GSH, and its chromatographic mobility was similar to that previously observed (6). The relative concentration and extent of this product formation was dependent upon the initial concentration of ONOO- and GSH. This product also showed a strong chromatographic peak when the HPLC analysis was performed with monitoring of UV absorbance at 334 nm, typical for nitro- and nitroso-thiols (2). Product b was not formed when GSH was treated with ONOO- at pH greater than 8 or with decomposed ONOO-, indicating that peroxynitrous acid was essential for formation of this product. A peak at 2.5 min and a broad peak at 5 min in the chromatogram on Fig. 3 (top) originated from the decomposition of ONOO-. Freezing of the ONOO-/GSH reaction mixture at -20 °C for 2-3 h markedly increased the abundance of product b near the upper frozen layer, via a freeze distillation, which allowed us to collect sufficient amounts of this material for mass spectrometric analyses. Product b, as well as synthetic GSNO and GSNO2, displayed sharp and reproducible chromatographic peaks on an RP-HPLC column; however, these three compounds had almost the same retention time and could not be separated on several HPLC systems. Thus, the identification of b based on retention time comparison with synthetic standards was not conclusive.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Chromatograms obtained by monitoring UV absorbance at 215 nm of the following samples analyzed by RP-HPLC. Top, reaction mixture obtained by incubation of GSH with peroxynitrite for 5 min at room temp; middle, GSH standard; bottom, GSNO2 standard.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Electrospray tandem mass spectrometry of products a and b obtained by reaction of glutathione with peroxynitrite and purified by RP-HPLC (as shown in Fig. 3). Top: mass spectrum of product b, identified as GSNO2 (collision energy, 25 eV); Bottom: mass spectrum of product a, which corresponds with GSH (collision energy, 10 eV).

Ultraviolet spectra of GSNO2 and GSNO showed minimal differences (Fig. 5). Both compounds displayed a relatively strong UV absorbance at 334 nm. The spectrum of GSNO showed a stronger deflection than the spectrum of GSNO2 at 218 nm. Because it was difficult to establish the structure of ONOO-/GSH product based on comparison with synthetic standards using UV and HPLC, we employed electrospray tandem mass spectrometry to elucidate the structure of this product.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5.   UV spectra of synthetic GSNO2 (top) and GSNO (bottom).

ESI mass spectrum of the ONOO-/GSH-derived product b contained a prominent ion at m/z 353 (Fig. 4), which presumably corresponds to a protonated form of the molecule. Thus, the molecular mass of this product was 352 atomic mass units, suggesting that product b had a structure consistent with S-nitroglutathione. This product displayed unusual stability under collision-induced activation tandem mass spectrometry, where ions were dissociated as a result of interaction with a neutral gas, argon. Our attempts to decompose ion m/z 353 at an energy of 25 eV caused a decrease in the detection of this ion by more than 90%, without producing any detectable ion fragments. In particular, ions that might be expected to originate from the loss of NO2, NO from the GSNO2H+, or decomposition of a GSH backbone could not be detected. Treatment of GSH with NO2BF4 yielded a compound that also produced a protonated GSNO2 ion at m/z 353, and it was also resistant to collisional activation (Fig. 6). Although the spectrum of ONOO-/GSH product was identical to that of synthetic GSNO2, the spectrum of synthetic GSNO was very different (Fig. 6). Collision-induced dissociation of the protonated GSNO ion (m/z 337) resulted in a loss of nitric oxide, producing an abundant fragment ion at m/z 307 (GSH+). The GSNOH+ right-arrow GSH+ fragmentation occurred readily, and therefore, the cleavage of the S-NO bond required relatively mild conditions. In the absence of additional ion activation, the mass spectrum of GSNO showed an ~8% relative abundance of the m/z 307 ion, suggesting that GSNOH+ ion was releasing NO (not shown). Additional loss of NO radical was observed under condition of a collision-induced dissociation of GSNOH+ ion at 9 eV, where approximately 80% of the S-NO bonds appear to have been broken (Fig. 6). Several minor ions were also observed in the mass spectrum of GSNO that originated from dissociation of the GSH backbone. Our mass spectrometric data provided evidence that the reaction of GSH with ONOO- produces a S-nitro derivative of GSH, and the protonated GSNO2 ion is considerably more stable to collision-activated dissociation than the protonated GSNO ion.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Electrospray tandem mass spectra of synthetic standards. S-nitroglutathione (GSNO2) (collision energy, 25 eV); S-nitrosoglutathione (GSNO) (collision energy, 9 eV).

The abundance of the HPLC peak corresponding to GSNO2 relative to GSH was 6.3% following a mixing of 1 mM GSH with 400 µM ONOO- for 5 min, suggesting that about 16% of the ONOO- appears to have been converted to GSNO2. Thus, our studies identified the biologically active substance derived from the reaction of GSH with ONOO- as GSNO2, and GSNO was not a detectable product of ONOO-/GSH reaction.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The results of the present study provide evidence for our recent suggestion (6) that GSNO2 is a somewhat stable product of the reaction of ONOO- with GSH. We have previously observed that a product of the reaction between ONOO- and GSH has the properties of a substance that slowly releases NO, and a product of this reaction was isolated and shown to cause what appeared to be a NO-mediated relaxation (2). In the present study, GSNO2 was synthesized, and its ability to spontaneously release NO was demonstrated. The data obtained also suggest that nitrated derivatives of glucose or carbon dioxide do not seem to be primary species contributing to the generation of NO from ONOO- under the conditions examined. Thus, GSNO2 may be a key participant in the generation of NO from ONOO- in the presence of GSH (Fig. 7).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 7.   Proposed pathways involving ONOO-, GSH, and GSNO2.

Mass spectra of a key product that results from the reaction of GSH with ONOO- detected an ion with an m/z of 353 that had a mass spectrum comparable with that of synthetic GSNO2 produced from the reaction of GSH with NO2BF4. The ONOO-/GSH-derived product was clearly different from synthetic GSNO, which was not a detectable product of this reaction. Interestingly, collisional activation of GSNO2 derived from either ONOO- or NO2BF4 with 25 eV did not produce fragment ions, whereas the ion with an m/z at 337 of GSNO readily fragmented at 9 eV. Although the actual origin of the gas phase stability of protonated form of GSNO2 is not yet known, previously reported (21) molecular orbital calculations on model thiol nitrates (RSNO2) suggest that they have a very low barrier for rearrangement to sulfenyl nitrites (RSONO). Thus, it is possible that rapid equilibration between these species provides a level of stabilization sufficient to prevent the fragmentation of GSNO2. The relative stability of GSNO2 in the electrospray conditions could be also influenced by the attachment of proton to GSNO2, a process that is less likely to occur in solution at neutral pH. In a buffered solution, other factors, such as solvation and ionic strength, may contribute to the release of NO from GSNO2. Further studies are needed to establish whether the protonation of GSNO2 enhances its stability in solution.

It has been previously reported that RSNO2 (R = tert-butyl) species release detectable amounts of NO (20). The rate of this decomposition is relatively low (about 105 s-1) and pH-independent in the neutral pH region of acetonitrile/phosphate buffer at room temperature (20). As a result of molecular orbital calculations, it was suggested that the rearrangement of thiol nitrates (RSNO2) to sulfenyl nitrites (RSONO) followed by the spontaneous decomposition of RSONO was a potential mechanism of NO generation (20, 21). It was also previously observed that tert-butylthionitrate releases NO through a mechanism that was inhibited by thiols, and this inhibitory effect of glutathione was seen in the present study with purified GSNO2. A reaction of thiols with RSNO2 resulting in the formation of nitrite and disulfide was suggested as an explanation for the observed decreased formation of NO (20). Thus, the release of NO from GSNO2 has similarities with previous observations of NO release from tert-butylthionitrate. Although it has been suggested that nitrated thiols are very unstable species (7, 8), the observed release NO form GSNO2 over a prolonged period suggests that these substances may be more stable than they were previously considered to be. Because the release of NO2 via a homolytic cleavage of the S-N bond is not likely to occur in thionitrates (21), a question that remains to be answered is whether NO derives from sulfinyl nitrite (GS(O)NO) or sulfenyl nitrite (GSONO) after rearrangement of the initially formed thionitrate (GSNO2) (Fig. 7).

The observation that glucose- and CO2/bicarbonate-containing buffers reduced the amount of NO generation from ONOO- in the presence of GSH and the absence of an identifiable effect of these buffer components on the release of NO from GSNO2 are consistent with previous observations on the chemistry of ONOO-. Whereas ONOO- reacts with CO2/bicarbonate to form an intermediate that enhances the efficiency of some of the nitration reactions caused by ONOO- (14-16), data in the present study suggest that this process does not enhance the formation of the key NO-generating species, which appears to be GSNO2. Although ONOO- reacts with glucose (and other hydroxylated substances) to produce nitrovasodilators (11, 12), it appears that the products that form may have less of a potential to release NO in the presence of excess GSH than the thiol-derived NO-releasing species that form in the absence of glucose. Thus, the NO-releasing species hypothesized in the present study to be GSNO2 appears to result from a reaction of GSH with ONOO- that is not catalyzed by glucose or CO2/bicarbonate. Because thiol radicals and nitrogen dioxide seem to be key initial products of the aqueous chemistry of ONOO- and thiols (8-10), perhaps thiol nitration is a result of a radical-radical reaction between these two reactive species.

Observations made in the present study on the reaction of ONOO- with GSH are consistent with GSNO2 being a key intermediate that participates in the generation of NO. Our recent studies on bovine coronary (22) and pulmonary (23) arteries have already provided evidence that concentrations of NO as low as 50 nM cause a level of intracellular ONOO- formation that produces a prolonged relaxation of these vascular segments as a result of a thiol-dependent process that participates in the regeneration of NO. In addition, GSNO2 was hypothesized to be a key metabolite of nitroglycerin over 20 years ago (24). Therefore, GSNO2 may be an important biologically active metabolite of NO oxidation and nitrovasodilator drug action.

    ACKNOWLEDGEMENT

We thank Dr. Jing Song Ni from the American Health Foundation (Valhalla, NY) for performing analyses of samples by mass spectrometry.

    FOOTNOTES

* This research was supported by Grants HL31069, HL43023, and HL34300 from the National Institutes of Health and Grant 950325 from the American Heart Association NY State Affiliate.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pharmacology, New York Medical College, Valhalla, NY 10595. Tel. and Fax: 914-594-3621; E-mail: michael_balazy{at}nymc.edu.

The abbreviations used are: ONOO-, peroxynitrite; GSH, glutathione; NO, nitric oxide; GSNO2, S-nitroglutathione; GSNO, S-nitrosoglutathione; HPLC, high performance liquid chromatography; RP, reverse-phase; ESI, electrospray ionization; MS/MS, tandem mass spectrometry.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Liu, S., Beckman, J. S., and Ku, D. D. (1994) J. Pharmacol. Exp. Ther. 268, 1114-1121[Abstract/Free Full Text]
  2. Wu, M., Pritchard, K. A., Jr., Kaminski, P. M., Fayngersh, R. P., Hintze, T. H., and Wolin, M. S. (1994) Am. J. Physiol. 266, H2108-H2113[Abstract/Free Full Text]
  3. Mayer, B., Schrammel, A., Klatt, P., Koesling, D., and Schmidt, K. (1995) J. Biol. Chem. 270, 17355-17360[Abstract/Free Full Text]
  4. Tarpey, M. M., Beckman, J. S., Ischiropoulos, H., Gore, J. Z., and Brock, T. A. (1995) FEBS Lett. 364, 314-318[CrossRef][Medline] [Order article via Infotrieve]
  5. Moro, M. A., Darley-Usmar, V. M., Goodwin, D. A., Read, N. G., Zamora-Pino, R., Feelisch, M., Radomski, M. W., and Moncada, S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 6702-6706[Abstract/Free Full Text]
  6. Davidson, C. A., Kaminski, P. M., Wu, M., and Wolin, M. S. (1996) Am. J. Physiol. 270, H1038-H1043[Abstract/Free Full Text]
  7. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) J. Biol. Chem. 266, 4244-4250[Abstract/Free Full Text]
  8. Zhang, H., Squadrito, G. L., Uppu, R. M., Lemercier, J. N., Cueto, R., and Pryor, W. A. (1997) Arch. Biochem. Biophys. 339, 183-189[CrossRef][Medline] [Order article via Infotrieve]
  9. Karoui, H., Hansert, B., Sand, P. J., Tordo, P., Bohle, D. S., and Kalyanaraman, B. (1997) Nitric Oxide Biol. Med. 1, 346-358
  10. Quijano, C., Alvarez, B., Gatti, R. M., Augusto, O., and Radi, R. (1997) Biochem. J. 322, 167-173
  11. Moro, M. A., Darley-Usmar, V. M., Lizasoain, I., Su, Y., Knowles, R. G., Radomski, M. W., and Moncada, S. (1995) Br. J. Pharmacol. 116, 1999-2004[Medline] [Order article via Infotrieve]
  12. White, C. R., Moellering, D., Patel, R. P., Kirk, M., Barnes, S., and Darley-Usmar, V. M. (1997) Biochem. J. 328, 517-524
  13. Dowell, F. J., and Martin, W. (1997) Eur. J. Pharmacol. 338, 43-53[CrossRef][Medline] [Order article via Infotrieve]
  14. Uppu, R. M., Squadrito, G. L., and Pryor, W. A. (1996) Arch. Biochem. Biophys. 327, 335-343[CrossRef][Medline] [Order article via Infotrieve]
  15. Denicola, A., Freeman, B. A., Trujillo, M., and Radi, R. (1996) Arch. Biochem. Biophys. 333, 49-58[CrossRef][Medline] [Order article via Infotrieve]
  16. Pryor, W. A., Lemercier, J. N., Zhang, H., Uppu, R. M., and Squadrito, G. L. (1997) Free Radical Biol. Med. 23, 331-338[CrossRef][Medline] [Order article via Infotrieve]
  17. Berlett, B. S., Levine, R. L., and Stadtman, E. R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2784-2789[Abstract/Free Full Text]
  18. Brien, J. F., McLaughlin, B. E., Nakatsu, K., and Marks, G. S. (1991) J. Pharmacol. Methods 25, 19-27[CrossRef][Medline] [Order article via Infotrieve]
  19. Balazy, M. (1994) Pol. J. Pharmacol. Pharm. 46, 593-600
  20. Artz, J. D., Yang, K., Lock, J., Sanchez, C., Bennett, B. M., and Thatcher, G. R. J. (1996) Chem. Commun. 1996, 927-928[CrossRef]
  21. Cameron, D. R., Borrajo, A. M. P., Bennett, B. M., and Thatcher, G. R. J. (1995) Can. J. Chem. 73, 1627-1638[CrossRef]
  22. Davidson, C. A., Kaminski, P. M., and Wolin, M. S. (1997) Nitric Oxide Biol. Med. 1, 244-253
  23. Davidson, C. A., Kaminski, P. M., and Wolin, M. S. (1997) Am. J. Physiol. 273, L437-L444[Abstract/Free Full Text]
  24. Keen, J. H., Habig, W. H., and Jakoby, W. B. (1976) J. Biol. Chem. 251, 6183-6188[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. S. Deeb, G. Hao, S. S. Gross, M. Laine, J. H. Qiu, B. Resnick, E. J. Barbar, D. P. Hajjar, and R. K. Upmacis
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite
J. Lipid Res., May 1, 2006; 47(5): 898 - 911.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Wu and R. Wang
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Park, J. Anrather, P. Zhou, K. Frys, G. Wang, and C. Iadecola
Exogenous NADPH Increases Cerebral Blood Flow Through NADPH Oxidase-Dependent and -Independent Mechanisms
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1860 - 1865.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. CUZZOCREA, E. MAZZON, L. DUGO, R. DI PAOLA, A. P. CAPUTI, and D. SALVEMINI
Superoxide: a key player in hypertension
FASEB J, January 1, 2004; 18(1): 94 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Jourd'heuil, F. L. Jourd'heuil, and M. Feelisch
Oxidation and Nitrosation of Thiols at Low Micromolar Exposure to Nitric Oxide. EVIDENCE FOR A FREE RADICAL MECHANISM
J. Biol. Chem., April 25, 2003; 278(18): 15720 - 15726.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Venketaraman, Y. K. Dayaram, A. G. Amin, R. Ngo, R. M. Green, M. T. Talaue, J. Mann, and N. D. Connell
Role of Glutathione in Macrophage Control of Mycobacteria
Infect. Immun., April 1, 2003; 71(4): 1864 - 1871.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. K. Leach, S. M. Black, R. K. Schmidt-Ullrich, and R. B. Mikkelsen
Activation of Constitutive Nitric-oxide Synthase Activity Is an Early Signaling Event Induced by Ionizing Radiation
J. Biol. Chem., May 3, 2002; 277(18): 15400 - 15406.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Balazy, T. Iesaki, J. L. Park, H. Jiang, P. M. Kaminski, and M. S. Wolin
Vicinal Nitrohydroxyeicosatrienoic Acids: Vasodilator Lipids Formed by Reaction of Nitrogen Dioxide with Arachidonic Acid
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 611 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H.-W. Shin and S. C. George
Microscopic modeling of NO and S-nitrosoglutathione kinetics and transport in human airways
J Appl Physiol, March 1, 2001; 90(3): 777 - 788.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Kleschyov, B. Muller, T. Keravis, M.-E. Stoeckel, and J.-C. Stoclet
Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2743 - H2751.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. J. Buckley and A. R. Whorton
Adaptive responses to peroxynitrite: increased glutathione levels and cystine uptake in vascular cells
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1168 - C1176.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. S. Wolin
Interactions of Oxidants With Vascular Signaling Systems
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1430 - 1442.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Boulos, H. Jiang, and M. Balazy
Diffusion of Peroxynitrite into the Human Platelet Inhibits Cyclooxygenase via Nitration of Tyrosine Residues
J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 222 - 229.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-L. Ma, F. Gao, B. L. Lopez, T. A. Christopher, and J. Vinten-Johansen
Peroxynitrite, a Two-Edged Sword in Post-Ischemic Myocardial Injury---Dichotomy of Action in Crystalloid- Versus Blood-Perfused Hearts
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 912 - 920.
[Abstract] [Full Text]